Keywords
Last Name
Institution

Jan N. Basile

Title
InstitutionMedical University of South Carolina
DepartmentGeneral Internal Medicine
AddressP.O. Box MSC 623
VAMC
109 Bee St.
Phone843-789-6680
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Basile J, Egan B, Punzi H, Ali S, Li Q, Patel M, Neutel J. Risk of Hospitalization for Cardiovascular Events with ├č-Blockers in Hypertensive Patients: A Retrospective Cohort Study. Cardiol Ther. 2018 Dec; 7(2):173-183. PMID: 30191469.
      View in: PubMed
    2. Bisognano JD, Basile JN. From the President, American Society of Hypertension. J Am Soc Hypertens. 2017 11; 11(11):697. PMID: 29054402.
      View in: PubMed
    3. Miller-Hodges E, Dominiczak AF, Jennings GL, Oparil S, Batlle DC, Elijovich F, Basile JN, Laffer CL, Oliveras A, Dhaun N. Hypertension and Its Complications in a Young Man With Autoimmune Disease. Hypertension. 2017 04; 69(4):536-544. PMID: 28242716.
      View in: PubMed
    4. Fleg JL, Evans GW, Margolis KL, Barzilay J, Basile JN, Bigger JT, Cutler JA, Grimm R, Pedley C, Peterson K, Pop-Busui R, Sperl-Hillen J, Cushman WC. Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance. Hypertension. 2016 10; 68(4):888-95. PMID: 27504006.
      View in: PubMed
    5. Weber MA, Bloch M, Bakris GL, Weir MR, Zappe DH, Dahlof B, Velazquez EJ, Pitt B, Basile JN, Jamerson K, Hua TA. Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy. J Clin Hypertens (Greenwich). 2016 Apr; 18(4):299-307. PMID: 27060568.
      View in: PubMed
    6. Basile JN. A Multifactorial Approach to Reduce Cardiovascular Disease in Type 2 Diabetes Mellitus: Now More Than Ever. Hosp Pract (1995). 2016; 44(1):9-20. PMID: 26781810.
      View in: PubMed
    7. Bloch MJ, Basile JN. Ambulatory blood pressure monitoring to diagnose hypertension--an idea whose time has come. J Am Soc Hypertens. 2016 Feb; 10(2):89-91. PMID: 26654344.
      View in: PubMed
    8. Basile JN. ASH 2015 Annual Primary Care Program: What you missed by not attending. J Am Soc Hypertens. 2015 Nov; 9(11):831-6. PMID: 26553600.
      View in: PubMed
    9. Piller LB, Simpson LM, Baraniuk S, Habib GB, Rahman M, Basile JN, Dart RA, Ellsworth AJ, Fendley H, Probstfield JL, Whelton PK, Davis BR. Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT. J Gen Intern Med. 2014 Nov; 29(11):1475-83. PMID: 25002161.
      View in: PubMed
    10. Gradman AH, Basile JN. Recent clinical trials. J Am Soc Hypertens. 2014 Oct; 8(10):770-4; quiz 775-6. PMID: 25418501.
      View in: PubMed
    11. Todoran TM, Basile JN, Zile MR. Renal sympathetic denervation for blood pressure control: a review of the current evidence and ongoing studies. J Clin Hypertens (Greenwich). 2014 May; 16(5):331-41. PMID: 24655555.
      View in: PubMed
    12. Basile JN, Bloch MJ. Analysis of recent papers in hypertension treatment of hypertension in the setting of acute intracerebral hemorrhage: still no clear answer on the best BP level to intervene or what BP goal to achieve. J Clin Hypertens (Greenwich). 2014 Jan; 16(1):1-3. PMID: 24325638.
      View in: PubMed
    13. Rahman M, Baimbridge C, Davis BR, Barzilay JI, Basile JN, Henriquez MA, Huml A, Kopyt N, Louis GT, Pressel SL, Rosendorff C, Sastrasinh S, Stanford C. Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHAT. Clin Nephrol. 2013 Oct; 80(4):235-48. PMID: 23816477.
      View in: PubMed
    14. Bloch MJ, Basile JN. Review of recent literature in hypertension: updated clinical practice guidelines for chronic kidney disease now include albuminuria in the classification system. J Clin Hypertens (Greenwich). 2013 Dec; 15(12):865-7. PMID: 24119153.
      View in: PubMed
    15. Basile JN, Bloch MJ. Analysis of recent papers in hypertension. Initial combination therapy provides more prompt blood pressure control and reduces cardiovascular events but remains underutilized. J Clin Hypertens (Greenwich). 2013 Aug; 15(8):523-5. PMID: 23889711.
      View in: PubMed
    16. Basile JN, Bloch MJ. Determining the relative antihypertensive potency and relative cardiovascular risk reduction associated with different thiazide and thiazide-type diuretics. J Clin Hypertens (Greenwich). 2013 Jun; 15(6):359-61. PMID: 23730981.
      View in: PubMed
    17. Basile JN. The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM). J Diabetes Complications. 2013 May-Jun; 27(3):280-6. PMID: 23375850.
      View in: PubMed
    18. Bloch MJ, Basile JN. Analysis of recent papers in hypertension: Treatment of obstructive sleep apnea with continuous positive airway pressure appears to decrease the incidence of incident hypertension. J Clin Hypertens (Greenwich). 2013 Feb; 15(2):85-7. PMID: 23339724.
      View in: PubMed
    19. Basile JN, Bloch MJ. Analysis of recent papers in hypertension: nighttime administration of at least one antihypertensive medication is associated with better blood pressure control and cardiovascular outcomes in patients with type 2 diabetes or chronic kidney disease. J Clin Hypertens (Greenwich). 2013 Jan; 15(1):2-4. PMID: 23282118.
      View in: PubMed
    20. Basile JN, Bloch MJ. Exposure to air pollution increases the incidence of hypertension and diabetes in black women living in Los Angeles. J Clin Hypertens (Greenwich). 2012 Nov; 14(11):819-20. PMID: 23126360.
      View in: PubMed
    21. Basile JN, Bloch MJ. NHANES data highlight the clinical characteristics of those with poorly controlled hypertension. J Clin Hypertens (Greenwich). 2012 Apr; 14(4):267-8. PMID: 22458751.
      View in: PubMed
    22. Bloch MJ, Basile JN. The Rheos Pivotol trial evaluating baroreflex activation therapy fails to meet efficacy and safety end points in resistant hypertension: back to the drawing board. J Clin Hypertens (Greenwich). 2012 Mar; 14(3):184-6. PMID: 22372779.
      View in: PubMed
    23. Cushman WC, Davis BR, Pressel SL, Cutler JA, Einhorn PT, Ford CE, Oparil S, Probstfield JL, Whelton PK, Wright JT, Alderman MH, Basile JN, Black HR, Grimm RH, Hamilton BP, Haywood LJ, Ong ST, Piller LB, Simpson LM, Stanford C, Weiss RJ. Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Clin Hypertens (Greenwich). 2012 Jan; 14(1):20-31. PMID: 22235820.
      View in: PubMed
    24. Bloch MJ, Basile JN. UK guidelines call for routine 24-hour ambulatory blood pressure monitoring in all patients to make the diagnosis of hypertension--not ready for prime time in the United States. J Clin Hypertens (Greenwich). 2011 Dec; 13(12):871-2. PMID: 22142345.
      View in: PubMed
    25. Bloch MJ, Basile JN. New British guidelines mandate ambulatory blood pressure monitoring to diagnose hypertension in all patients: not ready for prime time in the United States. J Clin Hypertens (Greenwich). 2011 Nov; 13(11):785-6. PMID: 22051420.
      View in: PubMed
    26. Bloch MJ, Basile JN. Spironolactone is more effective than eplerenone at lowering blood pressure in patients with primary aldosteronism. J Clin Hypertens (Greenwich). 2011 Aug; 13(8):629-31. PMID: 21806775.
      View in: PubMed
    27. Basile J. A new approach to glucose control in type 2 diabetes: the role of kidney sodium-glucose co-transporter 2 inhibition. Postgrad Med. 2011 Jul; 123(4):38-45. PMID: 21680987.
      View in: PubMed
    28. Bloch MJ, Basile JN. Catheter-based renal sympathetic nerve ablation controls blood pressure in more difficult-to-control patients taking multi-agent pharmacologic therapy. J Clin Hypertens (Greenwich). 2011 Jun; 13(6):455-7. PMID: 21649846.
      View in: PubMed
    29. Basile J, Babazadeh S, Lillestol M, Botha J, Yurkovic C, Weitzman R. Comparison of aliskiren/hydrochlorothiazide combination therapy with hydrochlorothiazide monotherapy in older patients with stage 2 systolic hypertension: results of the ACTION study. J Clin Hypertens (Greenwich). 2011 Mar; 13(3):162-9. PMID: 21366847.
      View in: PubMed
    30. Bloch MJ, Basile JN. Treating the black hypertensive in 2010: achieve lower targets while awaiting more definitive evidence. J Clin Hypertens (Greenwich). 2011 Jan; 13(1):1-4. PMID: 21214713.
      View in: PubMed
    31. Bloch MJ, Basile JN. Patient self-management improves blood pressure control. J Clin Hypertens (Greenwich). 2011 Feb; 13(2):138-40. PMID: 21272203.
      View in: PubMed
    32. Drexel C, Merlo K, Basile JN, Watkins B, Whitfield B, Katz JM, Pine B, Sullivan T. Highly interactive multi-session programs impact physician behavior on hypertension management: outcomes of a new CME model. J Clin Hypertens (Greenwich). 2011 Feb; 13(2):97-105. PMID: 21272197.
      View in: PubMed
    33. Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. J Clin Hypertens (Greenwich). 2011 Mar; 13(3):146-54. PMID: 21366845.
      View in: PubMed
    34. Bloch MJ, Basile JN. Meta-analysis concludes angiotensin receptor blocker use increases the risk of developing cancer: concerns about the science and the message. J Clin Hypertens (Greenwich). 2010 Sep; 12(9):661-3. PMID: 20883225.
      View in: PubMed
    35. Bloch MJ, Basile JN. In navigator, the angiotensin receptor blocker valsartin modestly reduced the progression to type 2 diabetes but had no effect on cardiovascular events in higher-risk patients with impaired glucose tolerance. J Clin Hypertens (Greenwich). 2010 Nov; 12(11):881-5. PMID: 21054776.
      View in: PubMed
    36. Bloch MJ, Basile JN. Combination angiotensin receptor blocker-neutral endopeptidase inhibitor provides additive blood pressure reduction over angiotensin receptor blocker alone. J Clin Hypertens (Greenwich). 2010 Oct; 12(10):809-12. PMID: 21029344.
      View in: PubMed
    37. Bloch MJ, Basile JN. Review of recent literature: Existing kidney disease classification guideline needs to incorporate degree of proteinuria with estimated glomerular filtration rate to more accurately predict cardiovascular and renal risk. J Clin Hypertens (Greenwich). 2010 Aug; 12(8):627-30. PMID: 20695941.
      View in: PubMed
    38. Basile JN. One size does not fit all: the role of vasodilating beta-blockers in controlling hypertension as a means of reducing cardiovascular and stroke risk. Am J Med. 2010 Jul; 123(7 Suppl 1):S9-15. PMID: 20609697.
      View in: PubMed
    39. Bakris GL, Basile JN, Giles TD, Taylor AA. The role of nitric oxide in improving endothelial function and cardiovascular health: focus on nebivolol. Am J Med. 2010 Jul; 123(7 Suppl 1):S2-8. PMID: 20609695.
      View in: PubMed
    40. Bloch MJ, Basile JN. Intensive blood pressure control in children slows progression of chronic kidney disease. J Clin Hypertens (Greenwich). 2010 Jul 01; 12(7):524-6. PMID: 20629816.
      View in: PubMed
    41. Bloch MJ, Basile JN. Is there accord in ACCORD? Lower blood pressure targets in type 2 diabetes does not lead to fewer cardiovascular events except for reductions in stroke. J Clin Hypertens (Greenwich). 2010 Jul 01; 12(7):472-7. PMID: 20629807.
      View in: PubMed
    42. Basile J. Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals. Integr Blood Press Control. 2010; 3:91-104. PMID: 21949625.
      View in: PubMed
    43. Bloch MJ, Basile JN. Angiotensin receptor blocker use may decrease the incidence and progression of Alzheimer's disease and dementia in older men but the strength of the evidence is questionable. J Clin Hypertens (Greenwich). 2010 Jun; 12(6):444-6. PMID: 20591090.
      View in: PubMed
    44. Bloch MJ, Basile JN. Percutaneous revascularization of the renal arteries offers no evidence of clinical benefit in patients with atherosclerotic renal artery stenosis--the ASTRAL trial. J Clin Hypertens (Greenwich). 2010 Apr; 12(4):292-4. PMID: 20433551.
      View in: PubMed
    45. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010 Apr 29; 362(17):1575-85. PMID: 20228401.
      View in: PubMed
    46. Gradman AH, Basile JN, Carter BL, Bakris GL, Materson BJ, Black HR, Izzo JL, Oparil S, Weber MA. Combination therapy in hypertension. J Am Soc Hypertens. 2010 Mar-Apr; 4(2):90-8. PMID: 20400053.
      View in: PubMed
    47. Bloch MJ, Basile JN. High adherence to antihypertensive therapy is rare but when present is associated with a decreased risk of cardiovascular events. J Clin Hypertens (Greenwich). 2010 Mar; 12(3):195-6. PMID: 20433535.
      View in: PubMed
    48. Basile JN, Bloch MJ. Identifying and managing factors that interfere with or worsen blood pressure control. Postgrad Med. 2010 Mar; 122(2):35-48. PMID: 20203454.
      View in: PubMed
    49. Bloch MJ, Basile JN. A lower blood pressure goal in patients without diabetes lessens the occurrence of left ventricular hypertrophy. J Clin Hypertens (Greenwich). 2010 Feb 01; 12(2):109-11. PMID: 20167035.
      View in: PubMed
    50. Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. J Am Soc Hypertens. 2010 Jan-Feb; 4(1):42-50. PMID: 20374950.
      View in: PubMed
    51. Bloch MJ, Basile JN. Largest meta-analysis to date suggests that patients at risk for cardiovascular disease events derive benefit from antihypertensive therapy regardless of baseline blood pressure and to reduce vascular events, lowering blood pressure is more important than choice of antihypertensive drug class. J Clin Hypertens (Greenwich). 2009 Dec; 11(12):743-5. PMID: 20021533.
      View in: PubMed
    52. Bloch MJ, Basile JN. Hypertension patients with multiple comorbidities are more likely to have their BP controlled within the VA healthcare system: unfounded concerns about pay-for-performance. J Clin Hypertens (Greenwich). 2009 Oct; 11(10):577-9. PMID: 19817939.
      View in: PubMed
    53. Basile J, Toth PP. Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy. South Med J. 2009 Oct; 102(10 Suppl):S1-S12. PMID: 19834426.
      View in: PubMed
    54. Basile J. Lessons learned from the ONTARGET and TRANSCEND trials. Curr Atheroscler Rep. 2009 Sep; 11(5):371-6. PMID: 19664381.
      View in: PubMed
    55. Glasser SP, Basile JN, Lackland DT. Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome? Hypertension. 2009 Nov; 54(5):954-5. PMID: 19720951.
      View in: PubMed
    56. Bloch MJ, Basile JN. Prior incarceration is associated with an increased risk for developing hypertension. J Clin Hypertens (Greenwich). 2009 Aug; 11(8):453-5. PMID: 19695034.
      View in: PubMed
    57. Bloch MJ, Basile JN. Heart failure in people younger than 50 years is more common in black than white Americans and is closely associated with poorly treated and controlled hypertension: the CARDIA study. J Clin Hypertens (Greenwich). 2009 Jul; 11(7):388-90. PMID: 19583637.
      View in: PubMed
    58. Stewart SH, Reuben A, Brzezinski WA, Koch DG, Basile J, Randall PK, Miller PM. Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension. Alcohol Alcohol. 2009 Sep-Oct; 44(5):464-7. PMID: 19535495.
      View in: PubMed
    59. Bloch MJ, Basile JN. Analysis of Recent Papers in Hypertension. J Clin Hypertens (Greenwich). 2009 May; 11(5):292-95. PMID: 19534038.
      View in: PubMed
    60. Egan BM, Basile JN, Rehman SU, Davis PB, Grob CH, Riehle JF, Walters CA, Lackland DT, Merali C, Sealey JE, Laragh JH. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens. 2009 Jul; 22(7):792-801. PMID: 19373213.
      View in: PubMed
    61. Bloch MJ, Basile JN. Analysis of recent papers in hypertension. J Clin Hypertens (Greenwich). 2009 Apr; 11(4):238-40. PMID: 19368588.
      View in: PubMed
    62. Insull W, Basile JN, Vo AN, Jiang P, Thakkar R, Padley RJ. Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME Study. J Clin Lipidol. 2009 Apr; 3(2):109-18. PMID: 21291800.
      View in: PubMed
    63. Basile JN. Antihypertensive therapy, new-onset diabetes, and cardiovascular disease. Int J Clin Pract. 2009 Apr; 63(4):656-66. PMID: 19220522.
      View in: PubMed
    64. Bloch MJ, Basile JN. Analysis of recent papers in hypertension, Jan Basile, MD, Senior Editor. J Clin Hypertens (Greenwich). 2009 Feb; 11(2):102-5. PMID: 19222677.
      View in: PubMed
    65. Ernst ME, Carter BL, Basile JN. All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective. J Clin Hypertens (Greenwich). 2009 Jan; 11(1):5-10. PMID: 19125852.
      View in: PubMed
    66. Bloch MJ, Basile JN. Analysis of recent papers in hypertension. Lack of legacy effect with more intensive blood pressure control in the long-term follow-up of the United Kingdom Prospective Diabetes Study. J Clin Hypertens (Greenwich). 2009 Jan; 11(1):46-9. PMID: 19125859.
      View in: PubMed
    67. Bloch MJ, Basile JN. Analysis of recent papers in hypertension. J Clin Hypertens (Greenwich). 2008 Dec; 10(12):956-8. PMID: 19120725.
      View in: PubMed
    68. Bloch MJ, Basile JN. In angiotensin-converting enzyme inhibitor-intolerant individuals, the angiotensin receptor blocker telmisartan does not reduce the incidence of major cardiovascular events in high-risk patients: lessons learned from the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects Wtih Cardiovascular Disease (TRANSCEND). J Clin Hypertens (Greenwich). 2008 Nov; 10(11):876-80. PMID: 19128279.
      View in: PubMed
    69. Bloch MJ, Basile JN. Analysis of recent papers in hypertension Jan Basile , MD , Senior Editor. J Clin Hypertens (Greenwich). 2008 Oct; 10(10):805-7. PMID: 19090884.
      View in: PubMed
    70. Cushman WC, Ford CE, Einhorn PT, Wright JT, Preston RA, Davis BR, Basile JN, Whelton PK, Weiss RJ, Bastien A, Courtney DL, Hamilton BP, Kirchner K, Louis GT, Retta TM, Vidt DG. Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich). 2008 Oct; 10(10):751-60. PMID: 19090876.
      View in: PubMed
    71. Bloch MJ, Basile JN. Analysis of recent papers in hypertension. J Clin Hypertens (Greenwich). 2008 Sep; 10(9):735-7. PMID: 18844771.
      View in: PubMed
    72. Basile JN. Rationale for fixed-dose combination therapy to reach lower blood pressure goals. South Med J. 2008 Sep; 101(9):918-24. PMID: 18708973.
      View in: PubMed
    73. Rahman M, Baimbridge C, Davis BR, Barzilay J, Basile JN, Henriquez MA, Huml A, Kopyt N, Louis GT, Pressel SL, Rosendorff C, Sastrasinh S, Stanford C. Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Am J Kidney Dis. 2008 Sep; 52(3):412-24. PMID: 18676075.
      View in: PubMed
    74. Bloch MJ, Basile JN. Primary hyperaldosteronism in patients with resistant hypertension may be less prevalent than previously reported: evidence against an epidemic. J Clin Hypertens (Greenwich). 2008 Aug; 10(8):655-7. PMID: 18780479.
      View in: PubMed
    75. Bloch MJ, Basile JN. Analysis of recent papers in hypertension. J Clin Hypertens (Greenwich). 2008 Jul; 10(7):582-4. PMID: 18607144.
      View in: PubMed
    76. Bloch MJ, Basile JN. Treating hypertension in the oldest of the old reduces total mortality: results of the Hypertension in the Very Elderly Trial (HYVET). J Clin Hypertens (Greenwich). 2008 Jun; 10(6):501-3. PMID: 18663821.
      View in: PubMed
    77. Bloch MJ, Basile JN. Analysis of recent papers in hypertension: a simple office-based tool to predict the development of hypertension. J Clin Hypertens (Greenwich). 2008 May; 10(5):415-6. PMID: 18453803.
      View in: PubMed
    78. Bloch MJ, Basile JN. Self measurement of blood pressure at home should complement rather than replace office blood pressure management. J Clin Hypertens (Greenwich). 2008 Apr; 10(4):324-6. PMID: 18468004.
      View in: PubMed
    79. Wright JT, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, Basile JN, Black HR, Dart R, Gupta AK, Hamilton BP, Einhorn PT, Haywood LJ, Jafri SZ, Louis GT, Whelton PK, Scott CL, Simmons DL, Stanford C, Davis BR. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2008 Jan 28; 168(2):207-17. PMID: 18227370.
      View in: PubMed
    80. Basile J. Shifting paradigms in defining and treating hypertension: addressing global risk with combination therapy. J Clin Hypertens (Greenwich). 2008 Jan; 10(1 Suppl 1):2-3. PMID: 18174777.
      View in: PubMed
    81. Basile JN. Clinical considerations and practical recommendations for the primary care practitioner in the management of anemia of chronic kidney disease. South Med J. 2007 Dec; 100(12):1200-7. PMID: 18090962.
      View in: PubMed
    82. Bloch mJ, Basile JN. Thresholds for diastolic blood pressure reduction in older patients with isolated systolic hypertension appear to be different depending on the presence or absence of underlying coronary heart disease. J Clin Hypertens (Greenwich). 2007 Dec; 9(12):977-9. PMID: 18183669.
      View in: PubMed
    83. Basile JN. Recognizing the link between CKD and CVD in the primary care setting: accurate and early diagnosis for timely and appropriate intervention. South Med J. 2007 May; 100(5):499-505. PMID: 17534087.
      View in: PubMed
    84. Bloch MJ, Basile JN. Analysis of recent papers in hypertension. J Clin Hypertens (Greenwich). 2007 May; 9(5):396. PMID: 17546794.
      View in: PubMed
    85. Cushman WC, Grimm RH, Cutler JA, Evans GW, Capes S, Corson MA, Sadler LS, Alderman MH, Peterson K, Bertoni A, Basile JN. Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007 Jun 18; 99(12A):44i-55i. PMID: 17599425.
      View in: PubMed
    86. Basile JN. Fixed-dose combination therapy in the treatment of hypertension: ready for prime time. South Med J. 2007 Apr; 100(4):343-4. PMID: 17458389.
      View in: PubMed
    87. Basile JN, Ventura H. A historical look at hypertension: celebrating 100 years with the Southern Medical Association. South Med J. 2006 Dec; 99(12):1412-3. PMID: 17233212.
      View in: PubMed
    88. Egan BM, Lackland DT, Igho-Pemu P, Hendrix KH, Basile J, Rehman SU, Okonofua EC, Quarshie A, Oduwole A, Onwuanyi A, Reed J, Obialo C, Ofili EO. Cardiovascular risk factor control in communities--update from the ASH Carolinas-Georgia Chapter, the Hypertension Initiative, and the Community Physicians' Network. J Clin Hypertens (Greenwich). 2006 Dec; 8(12):879-86. PMID: 17170614.
      View in: PubMed
    89. Bloch MJ, Basile J. Analysis of Recent Papers in Hypertension Jan Basile, MD, Senior Editor. J Clin Hypertens (Greenwich). 2006 Nov; 8(11):823-825. PMID: 29024439.
      View in: PubMed
    90. Basile J. Management of global risk across the continuum of hypertensive heart disease. J Clin Hypertens (Greenwich). 2006 Aug; 8(8 Suppl 2):21-30; quiz 39-40. PMID: 16894245.
      View in: PubMed
    91. Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, Alderman MH, Atlas SA, Basile JN, Cuyjet AB, Dart R, Felicetta JV, Grimm RH, Haywood LJ, Jafri SZ, Proschan MA, Thadani U, Whelton PK, Wright JT. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2006 Sep; 48(3):374-84. PMID: 16864749.
      View in: PubMed
    92. Basile JN, Chrysant S. The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy. J Hum Hypertens. 2006 Mar; 20(3):169-75. PMID: 16397516.
      View in: PubMed
    93. Basile J, Houston M, Ferrario CM. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction. J Cardiometab Syndr. 2006; 1(5):358-61. PMID: 17679795.
      View in: PubMed
    94. Bloomfield HE, Nelson DB, van Ryn M, Neil BJ, Koets NJ, Basile JN, Samaha FF, Kaul R, Mehta JL, Bouland D. A trial of education, prompts, and opinion leaders to improve prescription of lipid modifying therapy by primary care physicians for patients with ischemic heart disease. Qual Saf Health Care. 2005 Aug; 14(4):258-63. PMID: 16076789.
      View in: PubMed
    95. Egan BM, Basile J, Chilton RJ, Cohen JD. Cardioprotection: the role of beta-blocker therapy. J Clin Hypertens (Greenwich). 2005 Jul; 7(7):409-16. PMID: 16015051.
      View in: PubMed
    96. Miller PM, Anton RF, Egan BM, Basile J, Nguyen SA. Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens (Greenwich). 2005 Jun; 7(6):346-51. PMID: 16088298.
      View in: PubMed
    97. Basile J. The role of existing and newer calcium channel blockers in the treatment of hypertension. J Clin Hypertens (Greenwich). 2004 Nov; 6(11):621-29; quiz 630-1. PMID: 15538095.
      View in: PubMed
    98. Vidt DG, Basile JN. Hypertension curriculum review. The importance of systolic blood pressure elevation in elderly persons. J Clin Hypertens (Greenwich). 2004 Aug; 6(8):461-5. PMID: 15308886.
      View in: PubMed
    99. Moser M, Schocken DD, Basile JN, Cushman WC. Hypertension and heart failure. Roundtable discussion. J Clin Hypertens (Greenwich). 2004 Jun; 6(6):326-32. PMID: 15233113.
      View in: PubMed
    100. Barzilay JI, Davis BR, Bettencourt J, Margolis KL, Goff DC, Black H, Habib G, Ellsworth A, Force RW, Wiegmann T, Ciocon JO, Basile JN. Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study. J Clin Hypertens (Greenwich). 2004 Mar; 6(3):116-25. PMID: 15010644.
      View in: PubMed
    101. Basile JN. Analysis of recent papers in hypertension. J Clin Hypertens (Greenwich). 2004 Feb; 6(2):96-101. PMID: 14872149.
      View in: PubMed
    102. Basile JN, Lackland DT, Basile JM, Riehle JE, Egan BM. A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):18-25. PMID: 14724420.
      View in: PubMed
    103. Giles TD, Basile JN. Beta-blockers for preventing sudden cardiac death. Postgrad Med. 2003 Dec; 114(6 Suppl Role):30-4. PMID: 19667667.
      View in: PubMed
    104. Basile JN, Cohen JD. Beta-blockers for treatment of hypertension. Postgrad Med. 2003 Dec; 114(6 Suppl Role):11-7. PMID: 19667665.
      View in: PubMed
    105. Egan BM, Basile JN. Controlling blood pressure in 50% of all hypertensive patients: an achievable goal in the healthy people 2010 report? J Investig Med. 2003 Nov; 51(6):373-85. PMID: 14686641.
      View in: PubMed
    106. Basile JN. Optimizing antihypertensive treatment in clinical practice. Am J Hypertens. 2003 Sep; 16(9 Pt 2):13S-17S. PMID: 14511897.
      View in: PubMed
    107. Basile J. Analysis of recent papers in hypertension. Need for more aggressive blood pressure control in diabetes. J Clin Hypertens (Greenwich). 2003 Sep-Oct; 5(5):352-3. PMID: 14564137.
      View in: PubMed
    108. Basile JN. The Importance of Systolic Blood Pressure Control and Cardiovascular Disease Prevention. Curr Treat Options Cardiovasc Med. 2003 Aug; 5(4):271-277. PMID: 12834564.
      View in: PubMed
    109. Basile JN. Titration of beta-blockers in heart failure. How to maximize benefit while minimizing adverse events. Postgrad Med. 2003 Mar; 113(3):63-70; quiz 3. PMID: 12647475.
      View in: PubMed
    110. Basile JN. Systolic blood pressure elevation: it's where the action is. Drugs Aging. 2003; 20(4):287-8. PMID: 12641484.
      View in: PubMed
    111. Basile J. Coffee intake over 33 years is not associated with developing hypertension. J Clin Hypertens (Greenwich). 2002 Nov-Dec; 4(6):434. PMID: 12461309.
      View in: PubMed
    112. Basile J. Serial hemodynamic measurements allow better blood pressure control than clinical judgment in those with refractory hypertension. J Clin Hypertens (Greenwich). 2002 Nov-Dec; 4(6):434-5. PMID: 12461310.
      View in: PubMed
    113. Basile J. Gaining weight increases the risk for the development of heart failure. J Clin Hypertens (Greenwich). 2002 Nov-Dec; 4(6):433. PMID: 12461308.
      View in: PubMed
    114. Basile JN. Systolic blood pressure. BMJ. 2002 Oct 26; 325(7370):917-8. PMID: 12399325.
      View in: PubMed
    115. Rehman SU, Cope DW, Basile JN. Metastatic gastroesophageal adenocarcinoma to skeletal muscle: a unique event. South Med J. 2002 Sep; 95(9):1076-8. PMID: 12356116.
      View in: PubMed
    116. Egan BM, Lackland DT, Basile JN. American Society of Hypertension regional chapters: leveraging the impact of the clinical hypertension specialist in the local community. Am J Hypertens. 2002 Apr; 15(4 Pt 1):372-9. PMID: 11991226.
      View in: PubMed
    117. Basile J. Hypertension in the elderly: a review of the importance of systolic blood pressure elevation. J Clin Hypertens (Greenwich). 2002 Mar-Apr; 4(2):108-12, 119. PMID: 11927790.
      View in: PubMed
    118. Basile JN. Halting the progression of heart failure: finding the optimal combination therapy. Cleve Clin J Med. 2002 Feb; 69(2):104-5, 109-10, 112. PMID: 11990640.
      View in: PubMed
    119. Basile JN. Most antihypertensives have similar efficacy and safety: a meta-analysis. J Clin Hypertens (Greenwich). 2002 Jan-Feb; 4(1):50-1. PMID: 11821640.
      View in: PubMed
    120. Basile JN. Blood pressure reduction in those with cerebrovascular disease prevents secondary stroke. J Clin Hypertens (Greenwich). 2002 Jan-Feb; 4(1):47-8. PMID: 11821637.
      View in: PubMed
    121. Basile JN. ACE inhibitor-associated cough lessened with iron supplementation. J Clin Hypertens (Greenwich). 2002 Jan-Feb; 4(1):49-50. PMID: 11821639.
      View in: PubMed
    122. Basile JN. Estrogen replacement does not prevent recurrent stroke or death in postmenopausal women after an ischemic stroke. J Clin Hypertens (Greenwich). 2002 Jan-Feb; 4(1):48-9. PMID: 11821638.
      View in: PubMed
    123. Basile JN. Aspirin and angiotensin-converting enzyme inhibitors are safe when taken together after acute myocardial infarction in patients with left ventricular dysfunction. J Clin Hypertens (Greenwich). 2001 Nov-Dec; 3(6):376-7. PMID: 11723360.
      View in: PubMed
    124. Basile JN. Hypertension 2001: pearls for the clinician. South Med J. 2001 Nov; 94(11):1054-7. PMID: 11780673.
      View in: PubMed
    125. Basile JN. An angiotensin receptor blocker plus a diuretic is most effective in lowering blood pressure in the African American with hypertension on a supplemental salt diet. J Clin Hypertens (Greenwich). 2001 Sep-Oct; 3(5):316-8. PMID: 11675776.
      View in: PubMed
    126. Basile JN. Hypertension 2001: how will JNC VII be different from JNC VI? South Med J. 2001 Sep; 94(9):889-90. PMID: 11592748.
      View in: PubMed
    127. Basile JN. Do blacks with ventricular dysfunction benefit from ACE inhibitor therapy? J Clin Hypertens (Greenwich). 2001 Sep-Oct; 3(5):313-5. PMID: 11588410.
      View in: PubMed
    128. Basile JN. Analyzing the national cholesterol education program adult treatment panel III report: is new better? J Clin Hypertens (Greenwich). 2001 Sep-Oct; 3(5):292-5. PMID: 11588407.
      View in: PubMed
    129. Basile JN. Blacks with hypertension, renal insufficiency, and baseline proteinuria benefit more from ACE inhibition than from calcium channel blockade. J Clin Hypertens (Greenwich). 2001 Sep-Oct; 3(5):315-6. PMID: 11675775.
      View in: PubMed
    130. Basile JN. Renal insufficiency predicts cardiovascular disease in high-risk individuals: the benefit of ramipril in the HOPE study. Heart Outcomes and Prevention Evaluation. J Clin Hypertens (Greenwich). 2001 Jul-Aug; 3(4):256-7. PMID: 11498658.
      View in: PubMed
    131. Basile JN. Salt sensitivity predicts mortality independently of elevated blood pressure: a 27-year follow-up study. J Clin Hypertens (Greenwich). 2001 Jul-Aug; 3(4):258-9. PMID: 11505946.
      View in: PubMed
    132. Barzilay JI, Jones CL, Davis BR, Basile JN, Goff DC, Ciocon JO, Sweeney ME, Randall OS. Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2001 Apr; 24(4):654-8. PMID: 11315826.
      View in: PubMed
    133. Grimm RH, Margolis KL. Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension. 2001 Jan; 37(1):19-27. PMID: 11208751.
      View in: PubMed
    134. Basile J, Brzezinski WA. Analysis of Recent Papers in Hypertension. J Clin Hypertens (Greenwich). 2000 Oct; 2(5):349-355. PMID: 11416674.
      View in: PubMed
    135. Basile J, Brzezinski WA. Analysis of Recent Papers in Hypertension. J Clin Hypertens (Greenwich). 2000 Jul; 2(4):290-294. PMID: 11416664.
      View in: PubMed
    136. Basile J, Brzezinski WA. Analysis of Recent Papers in Hypertension. J Clin Hypertens (Greenwich). 2000 May; 2(3):227-232. PMID: 11416653.
      View in: PubMed
    137. Basile JN. Combination agents as a means of improving adherence and other aspects of the sixth Joint National Committee Report. South Med J. 2000 May; 93(5):534-6. PMID: 10832960.
      View in: PubMed
    138. Basile J, Brzezinski WA. Analysis of Recent Papers in Hypertension. J Clin Hypertens (Greenwich). 2000 Mar; 2(2):144-148. PMID: 11416640.
      View in: PubMed
    139. Basile J, Brzezinski WA. Analysis of Recent Papers in Hypertension. J Clin Hypertens (Greenwich). 2000 Jan; 2(1):56-59. PMID: 11416628.
      View in: PubMed
    140. Basile J. Analysis of Recent Papers in Hypertension. J Clin Hypertens (Greenwich). 1999 Nov; 1(3):233-235. PMID: 11416618.
      View in: PubMed
    141. Basile J, Brzezinski WA. Analysis of Recent Papers in Hypertension. J Clin Hypertens (Greenwich). 1999 Oct; 1(2):156-158. PMID: 11416609.
      View in: PubMed
    142. Basile J. Analysis of Recent Papers in Hypertension. J Clin Hypertens (Greenwich). 1999 Jul; 1(1):77-79. PMID: 11416597.
      View in: PubMed
    143. Plankey MW, Stevens J, Palesch Y, Basile JN, Griffin PR. Stability of basal metabolic rate over selected days of the menstrual cycle. Obes Res. 1995 May; 3(3):301-2. PMID: 7627780.
      View in: PubMed
    144. Basile JN, Liel Y, Shary J, Bell NH. Increased calcium intake does not suppress circulating 1,25-dihydroxyvitamin D in normocalcemic patients with sarcoidosis. J Clin Invest. 1993 Apr; 91(4):1396-8. PMID: 8386185.
      View in: PubMed
    Basile's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _